Effects on Fetal Development: Although there isnt definitive evidence to support harmful effects on fetal development, the FDA typically advises against the use of GLP-1 receptor agonists during pregnancy unless no safer alternatives are available
Anti-vascular endothelial growth factor therapy in pregnancy: What we know, what we dont know, and what we dont know we dont know
Over the next five years, the marketplace will only grow more crowded: cheaper generics, oral pills replacing injections, and an escalating marketing war as companies expand indications from diabetes and obesity into sleep apnea, fatty liver disease, even addiction
Dosing errors, contamination risk, storage problems, sterility issues, and inaccurate labeling can all create serious health concerns
Standard GLP-1 dosing typically uses higher doses to drive stronger appetite suppression and weight-loss outcomes GLP-1 + GIP Microdosing Tirzepatide is for individuals seeking metabolic support with greater comfort and control
